Cargando…

Leptin: A Novel Therapeutic Target in Alzheimer's Disease?

It is well established that the hormone leptin circulates in the plasma in amounts proportional to body fat content and it regulates food intake and body weight via its actions in the hypothalamus. However, numerous studies have shown that leptin receptors are widely expressed throughout the CNS and...

Descripción completa

Detalles Bibliográficos
Autores principales: Beccano-Kelly, Dayne, Harvey, Jenni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255100/
https://www.ncbi.nlm.nih.gov/pubmed/22254146
http://dx.doi.org/10.1155/2012/594137
_version_ 1782220961160888320
author Beccano-Kelly, Dayne
Harvey, Jenni
author_facet Beccano-Kelly, Dayne
Harvey, Jenni
author_sort Beccano-Kelly, Dayne
collection PubMed
description It is well established that the hormone leptin circulates in the plasma in amounts proportional to body fat content and it regulates food intake and body weight via its actions in the hypothalamus. However, numerous studies have shown that leptin receptors are widely expressed throughout the CNS and evidence is growing that leptin plays a role in modulating a variety of neuronal processes. In particular, recent studies have highlighted a potential cognitive enhancing role for leptin as it regulates diverse aspects of hippocampal synaptic function that are thought to underlie learning and memory processes including glutamate receptor trafficking, dendritic morphology, and activity-dependent synaptic plasticity. Characterisation of the novel actions of leptin in limbic brain regions is providing valuable insights into leptin's role in higher cognitive functions in health and disease.
format Online
Article
Text
id pubmed-3255100
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32551002012-01-17 Leptin: A Novel Therapeutic Target in Alzheimer's Disease? Beccano-Kelly, Dayne Harvey, Jenni Int J Alzheimers Dis Review Article It is well established that the hormone leptin circulates in the plasma in amounts proportional to body fat content and it regulates food intake and body weight via its actions in the hypothalamus. However, numerous studies have shown that leptin receptors are widely expressed throughout the CNS and evidence is growing that leptin plays a role in modulating a variety of neuronal processes. In particular, recent studies have highlighted a potential cognitive enhancing role for leptin as it regulates diverse aspects of hippocampal synaptic function that are thought to underlie learning and memory processes including glutamate receptor trafficking, dendritic morphology, and activity-dependent synaptic plasticity. Characterisation of the novel actions of leptin in limbic brain regions is providing valuable insights into leptin's role in higher cognitive functions in health and disease. Hindawi Publishing Corporation 2012 2012-01-02 /pmc/articles/PMC3255100/ /pubmed/22254146 http://dx.doi.org/10.1155/2012/594137 Text en Copyright © 2012 D. Beccano-Kelly and J. Harvey. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Beccano-Kelly, Dayne
Harvey, Jenni
Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
title Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
title_full Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
title_fullStr Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
title_full_unstemmed Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
title_short Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
title_sort leptin: a novel therapeutic target in alzheimer's disease?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255100/
https://www.ncbi.nlm.nih.gov/pubmed/22254146
http://dx.doi.org/10.1155/2012/594137
work_keys_str_mv AT beccanokellydayne leptinanoveltherapeutictargetinalzheimersdisease
AT harveyjenni leptinanoveltherapeutictargetinalzheimersdisease